On viable therapy strategy for a mathematical spatial cancer model describing the dynamics of malignant and healthy

Alexander S Bratus1, Svetlana Yu Kovalenko, Elena Fimmel

  • 1Moscow State University, GSP-1, Leninskie Gory, Moscow, Russian Federation. applmath1miit@yandex.ru.

Insights

This study models cancer drug treatment, optimizing therapy by switching between high-intensity drug application and drug cessation. The goal is to maximize patient survival time using a viable treatment strategy.

Area of Science:

  • Mathematical Oncology
  • Computational Biology
  • Pharmacodynamics

Background:

  • Cancer drug treatments involve complex interactions between drugs, malignant cells, and healthy cells.
  • Understanding these spatial dynamics is crucial for optimizing therapeutic outcomes.
  • Existing models may not fully capture the effects of intermittent drug administration.

Purpose of the Study:

  • To develop and analyze a mathematical spatial cancer model.
  • To investigate the impact of drug administration strategies on cancer treatment efficacy.
  • To identify optimal treatment protocols for maximizing patient survival time.

Main Methods:

  • A mathematical model using three nonlinear parabolic partial differential equations.
  • Simulation of spatial dynamics for malignant cells, healthy cells, and drug concentration.
  • Exploration of treatment strategies involving intensive therapy and relaxation phases.

Main Results:

  • The model describes the spatial dynamics of cancer cells and drug concentration.
  • Phase constraints on cell counts and drug dosage were incorporated.
  • The study identifies viable treatment strategies by optimizing drug administration schedules.

Conclusions:

  • Optimizing drug administration schedules, alternating between high-intensity and relaxation phases, can maximize therapy time.
  • The developed mathematical model provides a framework for understanding and designing cancer treatment strategies.
  • This approach offers a pathway towards viable treatment strategies for improved patient survival.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
853
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
56.3K